Bioxytran, Inc. announced that it has entered into an agreement to issue 1,612,903 common shares at an issue price of $0.31 per share for gross proceeds of $500,000 on June 8, 2023. The transaction will include participation from new investor, Triton Funds, LLC. In connection with the offering, we have agreed to pay WallachBeth Capital LLC, the dealer-manager for the offering, 4.5% of the gross proceeds in cash and warrants to acquire 4.5% of the shares, exercisable at 110% of the subscription price, and to also reimburse WallachBeth for reasonable expenses incurred in connection with the offering.